HQL
abrdn Life Sciences Investors
HQL
HQL
65 hedge funds and large institutions have $52.3M invested in abrdn Life Sciences Investors in 2022 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 23 increasing their positions, 18 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
14% less capital invested
Capital invested by funds: $60.6M → $52.3M (-$8.26M)
Holders
65
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$1.83M | |
| 2 | +$577K | |
| 3 | +$464K | |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
+$321K |
| 5 |
LCM
Landscape Capital Management
Englewood,
New Jersey
|
+$258K |
Top Sellers
| 1 | -$901K | |
| 2 | -$491K | |
| 3 | -$491K | |
| 4 |
AUB
Atlantic Union Bankshares
Glen Allen,
Virginia
|
-$395K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$385K |